Table 2.

Likelihood of Earlier Stage at Diagnosis According to Insurance Status^*

Insurance Type**	Unadjusted OR (95% CI)	Adjusted OR (95% CI)
Breast cancer (n = 5,446)
FFS (n = 4,924)	1.00	1.00
HMO (n = 664)	0.73 (0.63 – 0.85)	0.77 (0.65 – 0.91)
Mixed FFS/HMO (n=184)	0.73 (0.56 – 0.96)	0.78 (0.59 – 1.04)
Lung cancer (n = 7,804)
FFS (n=6,758)	1.00	1.00
HMO (n=811)	0.97 (0.85 – 1.11)	0.96 (0.83 – 1.11)
Mixed FFS/HMO (n=235)	1.02 (0.81 – 1.30)	1.01 (0.79 – 1.29)

^*Results of polychotomous logistic regression examining AJCC stage (0, I, II, III, IV) at diagnosis.

^**Insurance status during month of diagnosis and 12 month period prior to month of diagnosis (FFS=fee-for-service, HMO=Health Maintenance Organization)

Outcomes in bold are significant at p<0.05